1. Home
  2. BUR vs OGN Comparison

BUR vs OGN Comparison

Compare BUR & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burford Capital Limited

BUR

Burford Capital Limited

HOLD

Current Price

$8.77

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$7.22

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BUR
OGN
Founded
2009
1923
Country
Guernsey
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
BUR
OGN
Price
$8.77
$7.22
Analyst Decision
Strong Buy
Hold
Analyst Count
2
4
Target Price
$18.00
$11.75
AVG Volume (30 Days)
1.6M
4.5M
Earning Date
05-27-2026
05-14-2026
Dividend Yield
1.48%
1.10%
EPS Growth
N/A
N/A
EPS
0.28
0.72
Revenue
$413,360,000.00
$6,216,000,000.00
Revenue This Year
$70.60
N/A
Revenue Next Year
$19.62
$1.65
P/E Ratio
$30.14
$10.11
Revenue Growth
N/A
N/A
52 Week Low
$8.12
$6.18
52 Week High
$14.61
$15.88

Technical Indicators

Market Signals
Indicator
BUR
OGN
Relative Strength Index (RSI) 41.53 40.01
Support Level $8.19 $6.85
Resistance Level $9.79 $7.74
Average True Range (ATR) 0.36 0.36
MACD -0.09 -0.05
Stochastic Oscillator 34.53 40.52

Price Performance

Historical Comparison
BUR
OGN

About BUR Burford Capital Limited

Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: